{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:10:35Z","timestamp":1787220635854,"version":"build-2736575974"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold> To determine the metabolic effects of cancer-conditioned media on myotube metabolism and to understand whether the variability of these effects is associated with cancer cachexia progression.<\/jats:p><jats:p><jats:bold>Materials and methods:<\/jats:bold> We established single-cell clones from murine Lewis lung carcinoma (LLC) cells and generated conditioned media from each clonal line. Differentiated primary mouse myotubes were incubated with conditioned media derived from each individual clonal cell line. After initial analysis, we selected a specific LLC clonal cell line that failed to induce metabolic stress in myotubes for further investigation <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Short-term incubation with conditioned media from 10\/34 LLC clonal cells failed to affect oxygen consumption rate (OCR) in myotubes. Incubation with parental LLC-conditioned media decreased protein content and changed the expression of key regulators of muscle function in myotubes, but the incubation of conditioned media from a selected clone that failed to affect OCR in myotubes also did not affect protein content and expression of muscle regulators. Mice injected with parental LLC cells had a significantly reduced body mass and muscle wasting compared to the mice injected with cells derived from this selected LLC clone.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Factors secreted by LLC cells induce metabolic stress in primary myotubes and induce cancer cachexia in mice. However, a selected clonal LLC cell line that failed to induce metabolic stress in myotubes also promoted weaker catabolism in mice. These novel findings establish that early disruption of muscle oxidative metabolism is associated with cancer cachexia progression.<\/jats:p>","DOI":"10.3389\/fphys.2022.1033932","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T05:20:47Z","timestamp":1669612847000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Muscle metabolic stress determines cancer cachexia severity in mice"],"prefix":"10.3389","volume":"13","author":[{"given":"Christiano","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Goodyear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Brum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccr.2005.10.004","article-title":"Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia","volume":"8","author":"Acharyya","year":"2005","journal-title":"Cancer Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e21714","DOI":"10.1096\/fj.202100263R","article-title":"Cancer-induced muscle atrophy is determined by intrinsic muscle oxidative capacity","volume":"35","author":"Alves","year":"2021","journal-title":"FASEB J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"109197","DOI":"10.1016\/j.biopha.2019.109197","article-title":"Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting","volume":"117","author":"Alves","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"101012","DOI":"10.1016\/j.molmet.2020.101012","article-title":"Exercise training reverses cancer-induced oxidative stress and decrease in muscle COPS2\/TRIP15\/ALIEN","volume":"39","author":"Alves","year":"2020","journal-title":"Mol. Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argiles","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1152\/physiolgenomics.00061.2018","article-title":"Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice","volume":"50","author":"Blackwell","year":"2018","journal-title":"Physiol. Genomics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jcsm.12232","article-title":"Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice","volume":"8","author":"Brown","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e41701","DOI":"10.1371\/journal.pone.0041701","article-title":"Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure","volume":"7","author":"Cunha","year":"2012","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jcsm.12014","article-title":"Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic","volume":"6","author":"Dev","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nm.4093","article-title":"Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia","volume":"22","author":"Fukawa","year":"2016","journal-title":"Nat. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","article-title":"NF-kappaB-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia","volume":"289","author":"Guttridge","year":"2000","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1073\/pnas.1402714111","article-title":"Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7","volume":"111","author":"He","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.clnu.2019.08.003","article-title":"Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients","volume":"39","author":"Jouinot","year":"2020","journal-title":"Clin. Nutr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00520-014-2534-3","article-title":"Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer","volume":"23","author":"Kimura","year":"2015","journal-title":"Support. Care Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1101\/gad.10.10.1173","article-title":"MyoD is required for myogenic stem cell function in adult skeletal muscle","volume":"10","author":"Megeney","year":"1996","journal-title":"Genes Dev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A","article-title":"bFGF and LIF signaling activates STAT3 in proliferating myoblasts","volume":"19","author":"Megeney","year":"1996","journal-title":"Dev. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s13539-011-0028-4","article-title":"Combined approach to counteract experimental cancer cachexia: Eicosapentaenoic acid and training exercise","volume":"2","author":"Penna","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to Brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1096\/fj.13-240580","article-title":"Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia","volume":"28","author":"Puppa","year":"2014","journal-title":"FASEB J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.cell.2012.10.050","article-title":"A PGC-1\u03b1 isoform induced by resistance training regulates skeletal muscle hypertrophy","volume":"151","author":"Ruas","year":"2012","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molmet.2015.11.004","article-title":"Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia","volume":"5","author":"Schafer","year":"2016","journal-title":"Mol. Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/ijc.27494","article-title":"Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia","volume":"131","author":"Springer","year":"2012","journal-title":"Int. J. Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3945\/ajcn.116.140434","article-title":"Relation between hypermetabolism, cachexia, and survival in cancer patients: A prospective study in 390 cancer patients before initiation of anticancer therapy","volume":"105","author":"Vazeille","year":"2017","journal-title":"Am. J. Clin. Nutr."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.1033932\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T05:20:49Z","timestamp":1669612849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.1033932\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":31,"alternative-id":["10.3389\/fphys.2022.1033932"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.1033932","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"article-number":"1033932"}}